Intestinal T cell responses to gluten peptides are largely heterogeneous: Implications for a peptide-based therapy in celiac disease

Journal of Immunology

Volumn 182, Issue 7, 2009, Pages 4158-4166

  Camarca, Alessandra ^a   Anderson, Robert P ^b   Mamone, Gianfranco ^a   Fierro, Olga ^a   Facchiano, Angelo ^a   Costantini, Susan ^a   Zanzi, Delia ^c   Sidney, John ^d   Auricchio, Salvatore ^c   Sette, Alessandro ^d   Troncone, Riccardo ^c   Gianfrani, Carmen ^a  

^a CNR   (Italy)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLIADIN; GLUTAMINE; GLUTEN; GLUTENIN; HLA DQ2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; LEUCINE; PEPTIDE DERIVATIVE; PHENYLALANINE; PROLINE; TRYPTOPHAN; GAMMA INTERFERON; HLA DQ ANTIGEN; HLA DQ2 ANTIGEN, HUMAN; HLA-DQ2 ANTIGEN, HUMAN; PEPTIDE FRAGMENT;

ADULT; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELIAC DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; JEJUNUM MUCOSA; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN VARIANT; T LYMPHOCYTE; ADOLESCENT; AMINO ACID SEQUENCE; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; INTESTINE MUCOSA; MIDDLE AGED; MOLECULAR GENETICS;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CELIAC DISEASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLIADIN; GLUTENS; HLA-DQ ANTIGENS; HUMANS; INTERFERON-GAMMA; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 64249115818     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803181     Document Type: Article

References (42)

1. Jabri, B., and L. M. Sollid. 2006. Mechanisms of disease: immunopathogenesis of celiac disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 516-525.
2. Lundin, K. E. A., H. Sott, T. Hansen, G. Paulsen, T. S. Halstensen, O. Fausa, E. Thorsby, and L. Sollid. 1993. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 188: 187-196.
3. Molberg, O., K. Kett, H. Scott, E. Thorsby, L. M. Sollid, and K. E. Lundin. 1997. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46: 103-109. (Pubitemid 27298870)
4. Gianfrani, C., S. Auricchio, and R. Troncone. 2005. Innate and adaptive immune responses in celiac disease. Immunol. Lett. 99: 141-145. (Pubitemid 40966029)
5. Van de Wal, Y., Y. Kooy, P. van Veelen, S. Pena, L. Mearin, O. Molberg, K. Lundin, L. Sollid, T. Mutis, W. Benckhuijsen, et al. 1998. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc. Natl. Acad. Sci. USA 95: 10050-10054.
6. Vader, L., A. de Ru, Y. van der Wal, Y. M. Kooy, W. Benckhuijsen, M. L. Mearin, J. W. Drijfhout, P. van Veelen, and F. Koning. 2002. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J. Exp. Med. 195: 643-649. (Pubitemid 34461509)
7. Silano, M., and M. De Vincenzi. 1999. Bioactive antinutritional peptides derived from cereal prolamins: a review. Nahrung 3: 175-184. (Pubitemid 129570445)
8. Arentz-Hansen, H., R. Körner, O. Molberg, H. Quarsten, W. Vader, Y. M. Kooy, K. E. Lundin, F. Koning, P. Roepstorff, L. M. Sollid, and S. N. McAdam. 2000. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191: 603-612.
9. Arentz-Hansen, H., S. N. McAdam, O. Molberg, B. Fleckestein, K. E. Lundin, T. J. Jorgensen, G. Jumg, P. Roepstorff, and L. M. Sollid. 2002. Celiac lesion T cells recognized epitopes that cluster in regions of gliadin rich in proline residues. Gastroenterology 123: 803-809.
10. Tollefsen, S., H. Arentz-Hansen, B. Fleckenstein, O. Molberg, M. Raki, W. W. Kwok, G. Jung, K. E. A. Lundin, and L. M. Sollid. 2006. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J. Clin. Invest. 116: 2226-2236. (Pubitemid 44162332)
11. Molberg, O., S. N. McAdam, R. Körner, H. Quarsten, C. Kristiansen, L. Madsen, L. Fugger, H. Scott, O. Norén, P. Roepstorff, et al. 1998. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4: 713-717.
12. Sjöström, H., K. E. Lundin, O. Molberg, R. Körner, S. N. McAdam, D. Anthonsen, H. Quarsten, O. Norén, P. Roepstorff, E. Thorsby, and L. M. Sollid. 1998. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand. J. Immunol. 48: 111-115. (Pubitemid 28365999)
13. Mamone, G., P. Ferranti, D. Melck, F. Tafuro, L. Longobardo, L. Chianese, and F. Addeo. 2004. Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometry-based assay. FEBS Lett. 562: 177-182. (Pubitemid 38388467)
14. Shan, L., O. Molberg, I. Parrot, F. Hausch, F. Filiz, G. Gray, L. Sollid, and C. Khosla. 2002. Structural basis for gluten intolerance in celiac sprue. Science 297: 2275-2279.
15. Qiao, S. W., E. Bergseng, O. Molberg, J. Xia, Fleckenstein, C. Khosla, and L. M. Sollid. 2004. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J. Immunol. 173: 1757-1762.
16. Shan, L., S. W. Qiao, H. Arentz-Hansen, O. Molberg, G. M. Gray, L. M. Sollid, and C. Khosla. 2005. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implication for celiac sprue. J. Proteome Res. 4: 1732-1741. (Pubitemid 41464801)
17. Anderson, R. P., P. Degano, A. J. Godkin, D. P. Jewell, and A. V. S. Hill. 2000. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6: 337-342.
18. Vader, W., Y. Kooy, P. Van Vellen, A. De Ru, D. Harris, W. Benckhuijsen, S. Pena, L. Mearin, J. W. Drijfhout, and F. Koning. 2002. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122: 1729-1737. (Pubitemid 34651415)
19. Oldfield, W. L., A. B. Kay, and M. Larchè. 2001. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic asthmatic subjects. J. Immunol. 167: 1734-1739.
20. Leech, M. D., C. Y. Chung, A. Culshaw, and S. M. Anderton. 2007. Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis. Eur. J. Immunol. 37: 3576-3581.
21. Gianfrani, C., S. Auricchio, and R. Troncone. 2006. Possible drug targets for celiac disease. Exp. Opin. Ther. Targets 10: 601-611. (Pubitemid 44165130)
22. Gianfrani, C., R. Siciliano, A. Facchiano, A. Camarca, M. F. Mazzeo, S. Costantini, V. Salvati, F. Maurano, G. Mazzarella, G. Iaquinto, et al. 2007. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133: 780-789. (Pubitemid 47374136)
23. Gianfrani, C., M. K. Levings, C. Sartirana, G. Mazzarella, G. Barba, D. Zanzi, A. Camarca, G. Iaquinto, N. Giardullo, S. Auricchio, et al. 2006. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J. Immunol. 177: 4178-4186. (Pubitemid 44359953)
24. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95: 14863-14868.
25. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. ClustalW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673-4680.
26. Costantini, S., G. Colonna, and A. M. Facchiano. 2007. FASMA: a service to format and analyze the sequences in multiple alignments. Genomics Proteomics Bioinformatics 5: 253-255. (Pubitemid 351215125)
27. Sidney, J., M. F. Del Guercio, S. Southwood, and A. Sette. 2002. The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap peptide binding specificity. J. Immunol. 169: 5098-5108. (Pubitemid 35217179)
28. Sidney, J., S. Southwood, C. Oseroff, M. F. Del Guercio, A. Sette, and H. M. Grey. 2001. Measurement of MHC/peptide interactions by gel filtration. Curr. Protoc. Immunol. Chapter 18: Unit 18.3.
29. Southwood, S., J. Sidney, A. Kondo, M. F. Del Guercio, E. Appella, S. Hoffmann, R. T. Kubo, R. W. Grey, and A. Sette. 1998. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160: 3363-3373. (Pubitemid 28164729)
30. + T cell responses. Immunity 25: 533-543.
31. Assarsson, E., J. Sidney, C. Oseroff, V. Pasquetto, H. H. Bui, N. Frahm, C. Brander, B. Peters, H. Grey, and A. Sette. 2007. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J. Immunol. 178: 7890-7901. (Pubitemid 46898061)
32. Qiao, S. W., E. Bergseng, O. Molberg, G. Jung, B. Fleckenstein, and L. M. Sollid. 2005. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J. Immunol. 175: 254-261.
33. Maiuri, L., C. Ciacci, I. Ricciardelli, L. Vacca, V. Raia, S. Auricchio, J. Picard, M. Osman, S. Quaratino, and M. Londei. 2003. Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet 362: 30-37. (Pubitemid 36835817)
34. Hue, S., J. J. Mention, R. Monteiro, S. L. Zang, C. Cellier, J. Schmitz, V. Verkarre, N. Fodil, S. Bahram, N. Cerf-Bensussan, and S. Caillat-Zucman. 2004. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21: 367-377. (Pubitemid 39208338)
35. Van de Wal, Y., Y. M. Kooy, J. W. Drijfhout, R. Amons, and F. Koning. 1996. Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics 44: 246-253.
36. Vartdal, F., B. H. Johansen, T. Friede, C. J. Thorpe, S. Stevanović, J. E. Eriksen, K. Sletten, E. Thorsby, H. G. Rammensee, and L. M. Sollid. 1996. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur. J. Immunol. 2611: 2764-2772. (Pubitemid 26364857)
37. Costantini, S., M. Rossi, G. Colonna, and A. M. Facchiano. 2005. Modelling of HLA-DQ2 and of its interaction with gluten peptides to explain molecular recognition in celiac disease. J. Mol. Graph. Model. 23: 419-431. (Pubitemid 40386871)
38. Bergseng, E., J. Sidney, A. Sette, and L. M. Sollid. 2008. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules. Hum. Immunol. 69: 94-100.
39. Vanderlugt, C. L., and S. D. Miller. 2002. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2: 85-95.
40. Larchè, M., and D. C. Wraith. 2005. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat. Med. 11(Suppl.): S69-S76. (Pubitemid 40562306)
41. Raki, M., S. Tollefsen, O. Molberg, K. E. A. Lundin, L. M. Sollid, and F. Jahnsen. 2006. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 131: 428-438. (Pubitemid 44142462)
42. Di Sabatino, A., K. M. Pickard, J. N. Gordon, V. Salvati, G. Mazzarella, R. M. Beattie, A. Vossenkaemper, L. Rovedatti, N. A. Leakey, N. M. Croft, et al. 2007. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 133: 1175-1187. (Pubitemid 47494463)